Eric Lefkofsky Brings Change to Medical World With Tempus

Eric Lefkofsky first kickstarted his career with the public releases of companies InnerWorkings and Echo Global Logistics. While these are not widely known to the public, you probably are familiar with Groupon, his other company. Through these startups, Eric has already generated $1.79 billion and is set to bring in even more money as the years go on. He is continually looking to improve and scouting for new business opportunities.

More recently he and his partner Brad Keywell released an intricate genomic database for cancer called Tempus. This company has high goals and is meant for doctors to use in order to compare patient DNA. This will lead to more advanced treatments and therapy schedules. This might even allow some cancer patients to extend their lifetime or find an individual cure. Eric thought of this idea when he noticed how quickly technology was advancing compared to medicine. Doctors have huge amounts of data collected but no generalized database to analyze and compare it together. Eric is already working to introduce Tempus to the highest trafficked hospitals in order to begin gathering and analyzing data as soon as possible. The company also has a private lab where gene-sequencing investigations will occur.Eric is no longer directly involved with Groupon, though he is still a chairman. He has channeled the majority of his focus into Tempus which he believes will be more rewarding to others. He put Kevin White, esteemed geneticist, in a top position where his expertise can have great benefit to the company.

In addition to his business endeavors, Eric also works to give back to his community and help others. Alongside his wife, Eric created the Lefkofsky Family Foundation in 2006. It is a private charity foundation that strives to assist high-impact initiatives and improves the communities it services.He is also involved in the community outside his own foundation. He serves as an adjunct professor at the University of Chicago and wrote a book called Accelerated Disruption. He is the Chairman for Chicago’s Steppenwolf Theatre Company. He is also the Trustee of Lurie Children’s Hospital of Chicago, The Museum of Science and Industry, World Business Chicago, and the Art Institute of Chicago. Eric has devoted his entire life to bettering the lives of those around him.

Eric Lefkofsky Brings In Tempus To Aid In Cancer Treatment

Eric Lefkofsky is known for his grand success with regard to GroupOn. He could have continued to bask in that glory. But he wanted to aid in the treatment of cancer.

This realization dawned on him when his wife was detected with breast cancer. This was when he started looking for information regarding diagnosis of cancer, its treatment therapies and so on. This was when he realized that even though cancer is such a common disease today, there is little information available on it. This is why doctors are not able to take informed decisions. In the end, it impacts cancer patients and their treatments. Read News Here .

This is how Tempus was born. This is an operation system that is devised keeping the cancer patients in mind. Doctors required this in order to treat their patients. But developing something like Tempus would have required scientific steps. This is where Eric played a key role. He has years of experience in building successful businesses. These are related to aggregating vast amounts of data. This data has to be mined in order get insights that can help to advance the status of given industry.

Eric Lefkofsky made Tempus which allows partnering doctors to make use of its analytics system. This lets them learn more about their patients and formulate their treatment plans accordingly.

There are a number of health centers that are collaborating with Tempus in order to make use of it. One of these is the Abramson Cancer Center at the University of Pennsylvania. There are a number of local hospitals that have teamed up with Tempus. This includes the Lurie Comprehensive Cancer Center of the Northwestern University. Another is the Rush University Medical Center. There is a clinical trial group which is at the University of Chicago. Even this has teamed up with Tempus to make use of its data and services.

Lefkofsky is well aware that it is a long journey. There will be no quick results here. But he says that it will be an exciting journey. This is because he is getting technology to cancer and healthcare.

http://www.chicagobusiness.com/article/20161001/ISSUE01/310019995/can-eric-lefkofsky-save-your-life for more .